Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)

被引：0
|
作者：
Lee Schwartzberg
Sally Y. Barbour
Gary R. Morrow
Gianluca Ballinari
Michael D. Thorn
David Cox
机构：
[1] West Clinic,Department of Pharmacy
[2] Duke University Medical Center,undefined
[3] University of Rochester School of Medicine and Dentistry,undefined
[4] Helsinn Healthcare SA,undefined
[5] Statistics Resources,undefined
[6] Inc.,undefined
[7] Eisai Inc.,undefined
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Palonosetron; Serotonin antagonists; CINV; Nausea; Vomiting; Cancer chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：469 / 477
页数：8
相关论文
共 50 条
  • [1] Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Schwartzberg, Lee
    Barbour, Sally Y.
    Morrow, Gary R.
    Ballinari, Gianluca
    Thorn, Michael D.
    Cox, David
    SUPPORTIVE CARE IN CANCER, 2014, 22 (02) : 469 - 477
  • [2] Analysis of phase III clinical studies for palonosetron, ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
    Barbour, S. Y.
    Morrow, G. R.
    Ahmed, R.
    Ballinari, G.
    Thorn, M. D.
    Cox, D.
    Schwartzberg, L. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] ANALYSIS OF PHASE III STUDIES FOR PALONOSETRON, ONDANSETRON, DOLASETRON, AND GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PATIENTS WITH LUNG CANCER
    Schwartzberg, Lee
    Morrow, Gary R.
    Barbour, Sally Y.
    Ahmed, Raza
    Ballinari, Gianluca
    Thorn, Michael D.
    Cox, David
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S457 - S458
  • [4] Palonosetron versus ondansetron in CINV (chemotherapy-induced nausea and vomiting)
    Vieira, S.
    Monroe, D.
    Sorita, R.
    Palomar, M.
    Librojo, M.
    Porin, L.
    Ng, J.
    Taylor, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S370 - S370
  • [5] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    FEDELE, P
    SPINA, M
    VALENTINI, M
    COLLINI, D
    LUCIA, C
    MANICONE, M
    TIRELLI, U
    CANCER, 1995, 76 (03) : 535 - 536
  • [6] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - REPLY
    GEBBIA, V
    CANNATA, G
    GEBBIA, N
    CANCER, 1995, 76 (03) : 536 - 536
  • [7] Efficacy and Safety of Palonosetron Versus Ondansetron in Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Children
    Chaudhary, N.
    Boddu, D.
    John, R. R.
    Gowri, M. S.
    Nesadeepam, W. N.
    Mathew, L. G.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S17 - S17
  • [8] Phase III study of sustained release granisetron (APF530) compared to palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Grous, J. J.
    Riegel, E.
    Gabrail, N.
    Charu, V.
    Arevalo-Araujo, R.
    Yanagihara, R.
    Nguyen, A.
    Robertson, P.
    Cooper, B.
    O'Boyle, E.
    Barr, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (10) : 1019 - 1026
  • [10] Phase III study of NEPA, a fixed combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV).
    Zhang, Li
    Lu, Shun
    Feng, Ji Feng
    Dechaphunkul, Arunee
    Chessari, Salvatore
    Lanzarotti, Corinna
    Jordan, Karin
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345